Blau Farmaceutica SA
BOVESPA:BLAU3

Watchlist Manager
Blau Farmaceutica SA Logo
Blau Farmaceutica SA
BOVESPA:BLAU3
Watchlist
Price: 14.27 BRL -2.26%
Market Cap: 2.6B BRL

Intrinsic Value

The intrinsic value of one BLAU3 stock under the Base Case scenario is 25.53 BRL. Compared to the current market price of 14.27 BRL, Blau Farmaceutica SA is Undervalued by 44%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BLAU3 Intrinsic Value
25.53 BRL
Undervaluation 44%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Blau Farmaceutica SA

Valuation History Unavailable

Historical valuation for BLAU3 cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BLAU3?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Blau Farmaceutica SA
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Blau Farmaceutica SA

Current Assets 1.6B
Cash & Short-Term Investments 442.1m
Receivables 514.8m
Other Current Assets 690.4m
Non-Current Assets 1.8B
Long-Term Investments 265.2m
PP&E 882m
Intangibles 501.1m
Other Non-Current Assets 136.5m
Efficiency

Free Cash Flow Analysis
Blau Farmaceutica SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Blau Farmaceutica SA

Revenue
1.8B BRL
Cost of Revenue
-1.1B BRL
Gross Profit
688.6m BRL
Operating Expenses
-298.1m BRL
Operating Income
390.5m BRL
Other Expenses
-122.4m BRL
Net Income
268.1m BRL
Fundamental Scores

BLAU3 Profitability Score
Profitability Due Diligence

Blau Farmaceutica SA's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Operating Income
Positive 3-Year Average ROE
Positive 3-Year Average ROIC
56/100
Profitability
Score

Blau Farmaceutica SA's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

BLAU3 Solvency Score
Solvency Due Diligence

Blau Farmaceutica SA's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Positive Net Debt
60/100
Solvency
Score

Blau Farmaceutica SA's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BLAU3 Price Targets Summary
Blau Farmaceutica SA

Wall Street analysts forecast BLAU3 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BLAU3 is 18.3 BRL with a low forecast of 15.15 BRL and a high forecast of 23.63 BRL.

Lowest
Price Target
15.15 BRL
6% Upside
Average
Price Target
18.3 BRL
28% Upside
Highest
Price Target
23.63 BRL
66% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BLAU3 is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one BLAU3 stock?

The intrinsic value of one BLAU3 stock under the Base Case scenario is 25.53 BRL.

Is BLAU3 stock undervalued or overvalued?

Compared to the current market price of 14.27 BRL, Blau Farmaceutica SA is Undervalued by 44%.

Back to Top